New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy.
about
Cardiac cAMP: production, hydrolysis, modulation and detectionDisruption of adenylyl cyclase type V does not rescue the phenotype of cardiac-specific overexpression of Galphaq protein-induced cardiomyopathyIsoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compoundsGene targeting in ischemic heart disease and failure: translational and clinical studies.Gene therapy in heart failure.Adenylyl cyclase type 5 protein expression during cardiac development and stress.Bitransgenesis with beta(2)-adrenergic receptors or adenylyl cyclase fails to improve beta(1)-adrenergic receptor cardiomyopathy.GRK2 as a novel gene therapy target in heart failure.Targeted gene therapy for the treatment of heart failure.Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade.Gene therapy for myocardial infarction-associated congestive heart failure: how far have we got?Activation of PH-domain leucine-rich protein phosphatase 2 (PHLPP2) by agonist stimulation in cardiac myocytes expressing adenylyl cyclase type 6.The type VI adenylyl cyclase protects cardiomyocytes from β-adrenergic stress by a PKA/STAT3-dependent pathway.Principal role of adenylyl cyclase 6 in K⁺ channel regulation and vasodilator signalling in vascular smooth muscle cells.Rescuing a failing heart: putting on the squeeze.
P2860
Q26781612-941A2D85-C909-4CC0-91D7-8029B369A3AAQ34357713-2D3D2BD8-F1F8-42E8-B913-93D8D31221EDQ34978520-DF6FD9B5-30D6-4A2E-A8BC-8B0317238212Q36617570-86D199F1-747F-4109-9263-95386A96650AQ36944623-4057413D-C969-46B7-8E0A-B272CA0C6F8AQ37430967-72DCB664-1681-4643-AAE3-B30376B0D32FQ37700355-C8FFC455-F999-4E71-821A-8A611ACE90ADQ37783642-E1793621-6105-4103-9A74-D68B28D170DAQ37878086-9C98E012-3911-486F-AD06-9F69B00884D1Q37984182-5348B558-B08F-48A9-A797-6FC805AC3B6AQ40014132-CDD897F8-26CB-4F19-AA73-F7DBF48BDDADQ41587735-587BA8D5-24CF-4C77-9672-B4298263DC42Q41611394-EE709CCD-7CED-4ACA-8C90-B498F3B8AF38Q41846747-C5CD3B92-7B9D-4C37-8858-401E1A8EA830Q44389489-088E6B15-4E53-46EA-BF7E-0997D8C5A11C
P2860
New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
New signaling pathways associa ...... gestive heart failure therapy.
@ast
New signaling pathways associa ...... gestive heart failure therapy.
@en
type
label
New signaling pathways associa ...... gestive heart failure therapy.
@ast
New signaling pathways associa ...... gestive heart failure therapy.
@en
prefLabel
New signaling pathways associa ...... gestive heart failure therapy.
@ast
New signaling pathways associa ...... gestive heart failure therapy.
@en
P2093
P2860
P1476
New signaling pathways associa ...... gestive heart failure therapy.
@en
P2093
H Kirk Hammond
Huy M Phan
Mei Hua Gao
N Chin Lai
P2860
P304
P356
10.1016/J.TCM.2007.07.001
P577
2007-10-01T00:00:00Z